• Dr. Cohen on Radio in Vivo!

    Dr. Cohen has been in the news a lot lately!  Here’s him on another radio show, called Radio in Vivo!  A great way to learn about Dr. Cohen’s inspiration and drive to enter Alzheimer’s disease research.  Click the picture or … Continued

  • Dr. Todd Cohen in a Podcast!

    Dr. Todd Cohen was featured in “The News and Notes Podcast” by Jeffrey C. McAndrew, where they discussed new, promising discoveries in ALS and what a typical day is like in the Cohen Lab at UNC Chapel Hill. Press play … Continued

  • Inspiring Stories in Inclusion Body Myositis (sIBM)

    Dr. Todd Cohen and the efforts of the Cohen Lab were mentioned in the Oshkosh Herald!  The story below features the efforts of Gary Beyer, a patient with sporadic Inclusion Body Myositis (sIBM), a muscle weakening disease that is similar … Continued

  • Hanna Awarded an NSF Fellowship! UNC Biochemistry and Biophysics Spotlight

    Hanna was one of two Biochemistry and Biophysics students to be awarded the National Science Foundation (NSF) Fellowship!  An excerpt from the full article on the UNC School of Medicine website can be found below: Two biochemistry and biophysics grad … Continued

  • Unraveling Alzheimer’s: The Cohen Lab Publishes Again

    The Cohen Lab just published a new article, The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology in Cell Press, and the UNC School of Medicine Newsroom Interviewed Dr. Cohen on the article!  A sneak peak: Led by Todd Cohen, PhD, assistant … Continued

  • Cohen Lab ALS Research in the News!

    #UNC and @NCState researchers team up & find new clues about the causes of ALS and how to reverse the disease: https://t.co/snFOYply1T pic.twitter.com/HezsbyqWyp — UNC-Chapel Hill (@UNC) July 21, 2017

  • TDP-43 in Amyotrophic Lateral Sclerosis

     TDP-43 mediated neurodegeneration in Amyotrophic Lateral Sclerosis (ALS)  Like tau acetylation and phosphorylation in Alzheimer’s Disease, TDP-43 modifications similarly promote aberrant pathology seen in diseased brain and spinal cord of ALS and FTLD-TDP patients. Understanding such post-translational mechanisms could lead … Continued

  • Tau in Alzheimer’s Disease

    Tau-mediated neurodegeneration in Alzheimer’s disease  Tau acetylation causes increased tau aggregation in vitro and promotes the formation of tau tangles observed in AD brain (Cohen et al., Nat Commun, 2011).

  • Our Research Mission

    Our Research Mission in Todd Cohen’s Lab at UNC Chapel Hill One-liner: To identify the pathogenic mechanisms underlying neurodegenerative disease.    More specifically:  Although distinct, many of these diseases share common underlying pathogenic mechanisms.  We seek to uncover the molecular pathways … Continued

Welcome to Todd Cohen’s Lab website! The Cohen Lab at UNC Chapel Hill works within the department of Neurology at the Neuroscience Research Building.  We study the biochemistry of protein aggregation disorders including Alzheimer’s Disease and Amyotrophic Lateral Sclerosis (ALS).


Some things to do:

Please see our UNC job posting here, we’re hiring postdocs right now! We’re building both our Alzheimer’s and ALS research groups and now is the time to apply! Also, please post your application and also email me directly to ensure that your application gets my appropriate attention.

One Response to “Todd Cohen’s Lab at UNC Chapel Hill”

  1. Connor Wander

    We want to welcome Tejaz to the Cohen Lab! Tejaz is Deepa’s son, and will be helping us make important discoveries in neurodegenerative research!